Related Experiment Videos

Apoptosis. Molecules and mechanisms

M Konopleva1, S Zhao, Z Xie

  • 1Department of Molecular Hematology and Therapy, M.D. Anderson Cancer Center, University of Texas, Houston, USA.

Insights

This review details programmed cell death (apoptosis) pathways, including triggers, modulators like Bcl-2 family proteins, and effectors such as caspases. It explores the structure-function of Bcl-2 family members and their role in cancers.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Programmed cell death, or apoptosis, is a fundamental biological process crucial for development and tissue homeostasis.
  • Dysregulation of apoptosis is implicated in various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions.

Purpose of the Study:

  • To provide a comprehensive review of the molecular machinery governing apoptosis.
  • To elucidate the roles of various protein families, such as Bcl-2 and caspases, in regulating cell death.
  • To discuss the implications of apoptosis in diseases like leukemia and lymphoma and potential therapeutic strategies.

Main Methods:

  • Literature review synthesizing current knowledge on apoptosis.
  • Analysis of molecular pathways, including triggers, modulators, and effectors.
  • Examination of structure-function relationships, particularly for Bcl-2 family members.

Main Results:

  • Detailed classification of apoptosis components: triggers (chemotherapy, radiation, Fas ligation), modulators (Bcl-2 family, IAPs, FLICE, FLIPs), effectors (caspases 1-13), and substrates (PARP).
  • Emphasis on the structure-function dynamics of Bcl-2 family members and their post-transcriptional modifications.
  • Overview of apoptosis's role in leukemias and lymphomas.

Conclusions:

  • Apoptosis is a tightly regulated process involving a complex network of molecules.
  • Understanding these pathways, especially the Bcl-2 family, offers therapeutic targets for diseases characterized by aberrant cell death.
  • Modulating apoptotic pathways holds promise for treating cancers such as leukemia and lymphoma.

Related Concept Videos